Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck's Keytruda posts 24% response rate in PhII bladder cancer study
Merck's Keytruda posts 24% response rate in PhII bladder cancer study
Merck's Keytruda posts 24% response rate in PhII bladder cancer study
Submitted by
admin
on October 10, 2016 - 9:09am
Source:
Fierce Pharma
News Tags:
Merck
Keytruda
bladder cancer
Headline:
Merck's Keytruda posts 24% response rate in PhII bladder cancer study
Do Not Allow Advertisers to Use My Personal information
